Antibody Engineering & Therapeutics US San Diego

Antibody Engineering & Therapeutics US is the leading conference and trade show in North America dedicated to the latest scientific and technological advancements in antibody research and development. Each year, the global antibody community gathers at the Marriott Marquis San Diego Marina. This high-profile event is organized by Informa Connect, a business division of Informa PLC, a globally recognized organizer of scientific conferences. The choice of venue in California—one of the world’s most prominent biotech hubs—underscores the event’s importance and offers direct access to an innovative and economically vibrant environment.

The conference stands out for its clear thematic focus, placing a spotlight on forward-looking topics such as novel bispecific and multispecific antibody formats, therapeutic strategies for non-oncological indications (e.g., fibrosis, cardiovascular diseases, and CNS disorders), cell-activating approaches, in vitro and in vivo antibody discovery, innovative scaffolds, antibody-drug conjugates (ADCs) with next-generation payloads, and technical considerations around manufacturability and molecule selection. Special attention is given to extracellular protein degraders—a research area with high disruptive potential. In addition, the program addresses business-related topics such as commercialization, investment strategies, and regulatory developments.

What makes Antibody Engineering & Therapeutics US truly unique is its seamless integration of basic research with industrial application. The event showcases not only the latest scientific findings but also market-ready technologies and platform solutions—ranging from artificial intelligence in molecular design and cutting-edge display technologies to high-throughput screening methods, Fc engineering, T-cell engagers, knottin scaffolds, GPCR targeting, and the latest conjugation techniques for ADCs. Many of these innovations come directly from the laboratories of leading pharmaceutical companies, biotech firms, start-ups, and top-tier academic institutions.

The event serves as a central meeting point for experts across biotechnology, pharmaceuticals, medical technology, chemistry, AI-driven research, and clinical development. Attendees primarily come from research departments, business development, executive leadership, venture capital, as well as regulatory and strategic units. Numerous CROs, CDMOs, and platform providers are also represented.

Antibody Engineering & Therapeutics US is part of a global series of events, which includes international editions such as Antibody Engineering & Therapeutics Europe.

The venue—the Marriott Marquis San Diego—is located directly on the waterfront of the Californian coastal city, just minutes from San Diego International Airport. Downtown San Diego is within walking distance, as are numerous hotels, restaurants, and the region’s vibrant biotech scene.

For those seeking scientific excellence and innovation at the highest level, Antibody Engineering & Therapeutics US offers the ideal setting—where research, technology, and networking converge.

The Antibody Engineering & Therapeutics US will take place on 4 days from Sunday, 14. December to Wednesday, 17. December 2025 in San Diego.